How compounders plan to continue making GLP-1s
Why it matters: It would be the latest chapter in a battle with brand-name GLP-1 giants Novo Nordisk and Eli Lilly as millions try to get their hands on versions of the blockbuster drugs.
Driving the news: Noom, a digital health company that prescribes compound semaglutide, the active ingredient in some of Novo's GLP-1s, said it will continue to offer compounded versions of the drug beyond the May 22 enforcement deadline.
"The compounding law is clear," said CEO Geoff Cook. "There must be an individual patient benefit to the personalization. And so Noom works with [compounding] pharmacies to provide personalized medication when it's clinically indicated."
When prescribing a compounded GLP-1, Noom has been following a "low and slow" approach to titrating up dosages in patients in a way that is not available in commercial versions of GLP-1s.
Noom said it also prescribes brand name versions of GLP-1 products in a partnership announced earlier this year with Lilly Direct, as well as prescribing non-GLP-1 alternatives.
"I think we are looking to be on very firm ground on when it's clinically indicated," Cook said.
Yes, but: Pharma companies will likely challenge that interpretation.
"Compounders should have already transitioned patients to approved medicine, and anyone continuing to sell mass compounded tirzepatide, including by referring to it as 'personalized,' 'tailored' or something similar, is breaking the law and putting patients at risk," Eli Lilly said in a statement to Axios.
Catch up quick: The FDA allowed compounders to make cheaper copies of the drugs while they were in shortage.
When the agency declared Novo and Lilly's drugs were in sufficient supply earlier this year, compounders were put on notice that most versions of GLP-1s copies would not longer be allowed.
The compounding labs filed a challenge to put tirzepatide, the active ingredient in Lilly's GLP-1s, back in shortage. Earlier this month, a judge ruled against them.
The FDA also allows compounding for prescriptions specific to particular patients.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Apple analyst rethinks price target after $100 billion U.S. investment
Apple analyst rethinks price target after $100 billion U.S. investment originally appeared on TheStreet. All hands on deck! Captain Cook is taking the helm. Please note that we're not talking about the 18th century explorer James Cook, who led three voyages to the Southern and Pacific Oceans. 💵💰Don't miss the move: Subscribe to TheStreet's free daily newsletter 💰💵 We mean Apple () CEO Tim Cook, who has been guiding the Good Ship Cupertino through the turbulent tides of tariffs that followed President Trump's April 2 Liberation Day levy-palooza. Cook dropped anchor at the White House on Aug. 6 and joined Trump to announce that Apple was investing another $100 billion to expand its operations in the U.S. 'This is a significant step toward the ultimate goal of ensuring that iPhones sold in the United States of America also are made in America,' Trump said at the news conference. 'Today's announcement is one of the largest commitments in what has become among the greatest investment booms in our nation's history.' Apple said in February that it would invest $500 billion in the U.S. over the next four years and hire 20,000 U.S.-based workers. Apple shares surge on investment deal The company said at the time that it would build a new 250,000-square-foot manufacturing plant in Houston, set to open in 2026, that would make servers to power Apple's AI services. 'This includes new and expanded work with 10 companies across America,' Cook said in a statement. 'They produce components — semiconductor chips included — that are used in Apple products sold all over the world, and we're grateful to the President for his support.' More Tech Stocks: Analyst reboots SoFi Technologies price target after capital raise Amazon makes surprising decision to cut losses on recent deal Apple makes $100 billion genius move to skirt huge problem Trump also took time to say that he would slap tariffs of roughly 100% on imported semiconductors. "We'll be putting a tariff on of approximately 100% on chips and semiconductors, but if you're building in the United States of America, there's no charge, even though you're building and you're not producing yet," he said. Trump has criticized Cook and Apple for efforts to shift iPhone production to India to avoid the tariffs his administration had planned for China. In May, Trump threatened to impose a 25% tariff on iPhones made outside the U.S., writing on Truth Social that he told Cook that he expected iPhones that will be sold in the U.S. to be "manufactured and built in the United States, not India or anyplace else.' The announcement proved to be good news for Apple shares, which are off 12.2% this year. "Apple jumped more than 5% following news that it was increasing its capital investment in the U.S. by $100 billion," said TheStreet Pro's James "Rev Shark" DePorre in a recent column. "This strength offsets the weakness in thousands of smaller stocks." The investments are intended to bring more of Apple's supply chain and advanced manufacturing to the U.S. as part of an initiative called the American Manufacturing Program, but it is not a full commitment to build the iPhone domestically. Analyst says Apple may be exempt from tariffs The iPhone is Apple's most popular and profitable product as it consistently generates roughly half the company's total revenue each quarter. Wedbush analyst Dan Ives praised Cook's efforts to make peace with the White House."Cook has navigated this unprecedented tariff situation, proving that he is 10% politician and 90% CEO and [that at] times like this he will be using his strong ties globally to make sure it's smoother waters for Cupertino ahead despite concerns around AAPL's growth initiatives with Trump heading down the 'America First'/tariff path," Ives said. He maintained an outperform rating and $270 price target on Apple. But he also said that producing iPhones in the US remains "unrealistic given the cost structure vs. Asia/India and remains a fairy-tale concept. ... Apple will invest in Macs, AI, and a host of other tangential initiatives, but NOT core flagship iPhones being built in the U.S." Bank of America Securities analyst Wamsi Mohan and his team boosted their price target for Apple by 10 bucks to $250 while reiterating their buy rating. "Given the recent development of Apple's increased investment in the US, it seems increasingly likely that several Apple products will be exempt from tariffs," the firm said. Apple has the potential to gain smartphone market share in the U.S. "if competitors are exposed to tariffs while iPhones were to remain exempt," he said. While the the specifics are still unclear, B of A said, Apple seems likely to be exempt from at least the announced 100% tariff on semiconductors if not totally exempt. "If exempt, we believe estimates would be revised higher as Apple guided a $1.1 billion impact from tariffs for their [fiscal fourth quarter] after incurring $800 million in tariff-related costs in" fiscal Q3, the investment firm analyst rethinks price target after $100 billion U.S. investment first appeared on TheStreet on Aug 9, 2025 This story was originally reported by TheStreet on Aug 9, 2025, where it first appeared. Sign in to access your portfolio
Yahoo
19 hours ago
- Yahoo
Why Eli Lilly Stock Sank 18% This Week
Key Points Eli Lilly is seeing strong growth from its weight loss drugs. Investors are nervous about tariffs on drugs and weak data from its upcoming pipeline. The stock is cheaper but still trades at a premium valuation. 10 stocks we like better than Eli Lilly › Shares of Eli Lilly (NYSE: LLY) sank 18% this week, according to data from S&P Global Market Intelligence. The drugmaker with a market cap of over $500 billion is in a sharp drawdown due to previously high expectations and weak data on its obesity drug pipeline. Even though the stock is in a 35% dip from all-time highs, Eli Lilly is up 300% in the last five years on the back of its blockbuster weight loss drugs. Here's why Lilly stock dipped after posting its second-quarter results. Expansion of weight loss drugs miss expectations The top-line figures looked strong for the second quarter. Revenue grew 38% year over year to $15.5 billion, driven by gains for its weight loss drugs. Mounjaro revenue grew 68% year over year to $5.2 billion in the quarter, while Zepbound grew 172% to $3.4 billion. Net income was also rock solid, up 91% to $5.56 billion. Investors were likely pleased to see these revenue gains and profit margins expand. There is still plenty of opportunity to get more and more obese people taking these weight-loss drugs around the globe, given that there are an estimated 1 billion or more obese people today. So why did the stock drop? For two reasons: First is the uncertainty over pharmaceutical tariffs placed by the United States on foreign imports, which could have a large impact on Eli Lilly's cost structure. Second is the data on results from a new weight-loss drug called orfoglipron showing that it had large drop-out rates when taken during a trial. This made investors pessimistic on the company's drug pipeline. Time to buy the dip? Eli Lilly is guiding for just over $20 in earnings per share (EPS) this year, and it trades at a forward price-to-earnings ratio (P/E) of 28. This is much cheaper than it traded at a year ago, but it is not a dirt cheap valuation and a bit of a surprise for a stock in a 35% drawdown. Its previous P/E was quite the premium. Growth from these blockbuster drugs should continue through the rest of this decade, which will lead to further operating leverage and growth for Eli Lilly in EPS. For that reason, the stock is likely a good buy for investors searching for a solid stock in the midst of this booming bull market. Should you buy stock in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,563!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,108,033!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Eli Lilly Stock Sank 18% This Week was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
19 hours ago
- CNBC
From Starbucks to Smoothie King, restaurants seek to cash in on consumers' protein frenzy
Restaurant chains are joining in on the protein frenzy, hoping to encourage diners to pay more for extra macronutrients during a time when many consumers aren't spending as much. From "gym bros" to users of GLP-1 drugs like Ozempic, many Americans are trying to add more protein to their diets, with the goal of building or maintaining their muscle mass and feeling more satiated after meals. Moreover, diet trends that don't emphasize protein intake, such as the ketogenic diet, have fallen out of favor. "A lot of younger consumers are more proactive about their health habits, so they're looking for ways to support health now but also to support their health in the future," said Julia Mills, a food and drink analyst for market research firm Mintel. "Generation Alpha, Gen Z, millennials — these consumers are very active on social media, so they're constantly being fed this message that you need more protein, and protein helps you gain muscle and makes you stronger." Roughly a third of consumers said they loved high protein in the second quarter of 2025, up from 24% three years ago, according to Datassential, which tracks restaurant menus and consumer preferences. The trend has fueled a protein takeover in grocery store aisles, from protein-packed Eggo waffles to Khloe Kardashian's Khloud protein popcorn. But it's also hitting the menus of restaurants that are seeking ways to encourage diners to pay for premium food and drinks. Take Starbucks, for example. The coffee giant said in late July that it will roll out a cold foam packed with 15 grams of protein later this year; the regular cold foam add-on typically costs customers an extra $1.25 per drink. The new foam comes as the chain's U.S. sales have been shrinking for the past year as coffee drinkers brew their java at home or seek out trendier options. Rival Dutch Bros launched a protein coffee in early 2024 and charges customers an extra $1 for the customization. The menu addition fueled strong same-store sales growth and profits for the upstart chain. Eateries are seeking to attract diners like Jared Hutkowski, a 42-year-old director of brokerage in Harrisburg, Pennsylvania. He works out six days a week and tries to hit his daily protein goal to improve his physique and overall health. When he dines out, he tries to maximize his protein, although he sometimes goes for pizza anyway. "The biggest factor is what I am in the mood for that day, and then I normally try and select a meal that has a least a serving of some type of protein in it," Hutkowski said. This year, 28.4% of U.S. restaurant menus call out "protein," up from 5.9% a decade ago, according to Datassential. And the trend looks like it has staying power. Datassential predicts that by 2029, more than 40% of eateries will highlight protein on their menus. "Protein is one of those things that's never been vilified, because no one's ever said that eating too much protein can be bad for you," Mintel's Mills said. In the short term, consuming more protein than your body needs likely won't cause health issues, but in the long term, it could cause kidney problems, according to Diane Han, a registered dietitian based in San Francisco and the founder of Woking Balance Wellness. The recommended daily amount of protein intake varies by body weight but is roughly 46 grams for women and 56 grams for men, according to the Centers for Disease Control and Prevention. For restaurants, protein's step change happened several years ago. In 2021, protein only had a menu penetration of 11.5%; by 2022, more than a quarter of restaurant menus used the term, based on Datassential data. That year, Dine Brands' IHOP, for example, introduced pancakes with 18 grams of protein per flapjack. Fast-casual eateries are the restaurant segment most likely to call out protein on their menus, thanks to the common practice of asking customers to pick their protein or offering to double their portion, according to Datassential. Fast-casual salad chain Sweetgreen introduced a line of "protein plates" in late 2023 as part of an effort to introduce more hearty options for dinner customers. The menu addition has helped the company grow its dinner business from 35% of sales to about 40%, executives said in March. Many restaurants are also leaning into U.S. consumers' desire for convenience. Accessibility may be why Datassential found that consumers tend to prefer protein-packed beverages. For Smoothie King, protein has been a menu staple since its founding more than 50 years ago. But in October, the chain took one step further, launching a menu aimed at consumers who take GLP-1 drugs for weight loss or diabetes. The rapid weight loss that can occur from the medications can cause muscle mass to drop, so doctors often advise patients to increase their protein intake to maintain their muscle. "It's a convenient, on-the-go way to get in your protein that you're looking for in your diet," said Lori Primavera, Smoothie King's vice president of research and development and product marketing. Many restaurants are also choosing to highlight existing protein-packed options, rather than adding new menu items that would slow down kitchens or add to much complexity to their operations. For example, Panda Express introduced its own protein plates earlier this year. The line, created in partnership with a registered dietitian, includes pre-existing menu items but packages them as a balanced meal, highlighting protein and fiber content. Chipotle Mexican Grill employed a similar strategy back in 2019 when it introduced "lifestyle bowls," marketed to fit different dietary goals, like the paleo diet or offering double protein. Likewise, in July, Chick-fil-A put the spotlight on its own high-protein options in a company blog, highlighting its grilled nuggets and the Cool Wrap, which features a grilled chicken breast, cheese and lettuce in a tortilla. But for the eateries that want to add new menu items, nachos with a choice of protein, restaurant-made protein bars and egg dishes that highlight high protein content are all increasingly popular options, according to Datassential trendologist Claire Conaghan. Eggs are one reason why breakfast, brunch and lunch eatery First Watch has always been "protein forward," CEO Chris Tomasso told CNBC. The chain hasn't adjusted its menu specifically to address consumers' demand for more protein, but TikTok influencers have highlighted how to order a high-protein meal when visiting its restaurants. "We hope that continues to be a trend because we're right down the middle of the fairway on that," Tomasso said. Of course, protein isn't the only way to win over health-conscious consumers. Hutkowski said his primary issue with eating at restaurants is that most of the food is cooked in oils, butter and heavy greases that rapidly add to his intake of fats for the day. "A restaurant finding cleaner ways to cook would be much more attractive to me than overly loaded protein dishes," he said.
